Related Experiment Video
Updated: Jul 8, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Unmasking complex polymerization interferences in multiple myeloma diagnostics: A case study
Dan Han1, Emily A Wolters1, Folagbayi K Arowolo1
1Icahn School of Medicine at Mount Sinai, Department of Pathology, Molecular and Cell-Based Medicine, 1425 Madison Avenue, 8th Floor, Room 8-52, New York, NY 10029, United States of America.
Abstract:
Monoclonal gammopathies, defined by the clonal overexpression of immunoglobulins, are typically diagnosed using serum protein electrophoresis (SPEP), immunofixation electrophoresis (IFE), and serum free light chain (FLC) assays. However, atypical immunoglobulin structures can introduce diagnostic challenges. We describe a case of IgG-lambda multiple myeloma presenting with a double M-spike on SPEP: one in the anodal gamma region and another in the cathodal gamma region, mimicking biclonal gammopathy. IFE showed biclonal-like lambda bands, and serum lambda FLC levels were markedly elevated by turbidimetric analysis. These discrepancies were resolved following treatment with dithiothreitol (DTT), which disrupted disulfide-linked lambda FLC polymers, confirming that polymerization was the source of the assay interferences. This case study highlights the critical role of DTT treatment in FLC lambda multiple myeloma that by breaking FLC lambda polymers into monomers, the overestimation by turbidimetric method of FLC lambda level can be dramatically improved.

